These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 198562
1. Epstein-Barr virus and nasopharyngeal carcinoma: is there an etiologic relationship? Henderson BE, Louie EW, Jing JS, Alena B. J Natl Cancer Inst; 1977 Nov; 59(5):1393-5. PubMed ID: 198562 [Abstract] [Full Text] [Related]
2. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I. J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351 [Abstract] [Full Text] [Related]
3. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan. Tamada A, Makimoto K, Yamabe H, Imai J, Hinuma Y, Oyagi A, Araki T. Cancer; 1984 Feb 01; 53(3):430-40. PubMed ID: 6318948 [Abstract] [Full Text] [Related]
4. Nasopharyngeal carcinoma in Japan--clinical evaluation of EBV serology and EBV-associated nuclear antigens test. Takimoto T, Furukawa M, Morishita K, Umeda R, Hatano M. Auris Nasus Larynx; 1982 Feb 01; 9(3):151-63. PubMed ID: 6301414 [Abstract] [Full Text] [Related]
5. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT). Takimoto T, Kamide M, Umeda R. Arch Otorhinolaryngol; 1984 Feb 01; 239(1):87-92. PubMed ID: 6318711 [Abstract] [Full Text] [Related]
6. Immunity to antigens associated with a cell line derived from nasopharyngeal cancer (NPC) in non-Chinese NPC patients. Levine PH, De Thé GB, Brugere G, Schwaab G, Mourali N, Herberman RB, Ambrosioni JC, Revol P. Int J Cancer; 1976 Feb 15; 17(2):155-60. PubMed ID: 175025 [Abstract] [Full Text] [Related]
7. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK, Harijadi A, Haryana SM, Ng MH, Middeldorp JM. J Infect Dis; 2004 Jul 01; 190(1):53-62. PubMed ID: 15195243 [Abstract] [Full Text] [Related]
8. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma. Cevenini R, Donati M, Caliceti U, Moroni A, Tamba I, Rumpianesi F. J Infect; 1986 Mar 01; 12(2):127-31. PubMed ID: 3009628 [Abstract] [Full Text] [Related]
9. Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups. Lin TM, Yang CS, Chiou JF, Tu SM, Chen TY, Tu YC, Lin PJ, Kawamura A, Hirayama T. Am J Epidemiol; 1977 Oct 01; 106(4):336-9. PubMed ID: 199059 [Abstract] [Full Text] [Related]
10. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma. Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W. Int J Infect Dis; 2014 Aug 01; 25():110-5. PubMed ID: 24878579 [Abstract] [Full Text] [Related]
11. Selected observations on the epidemiology of pharyngeal cancers. Louie E, Henderson BE, Buell P, Jing JS, Menck HR, Pike MC. Natl Cancer Inst Monogr; 1977 Dec 01; 47():129-33. PubMed ID: 206840 [Abstract] [Full Text] [Related]
12. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Pearson GR, Weiland LH, Neel HB, Taylor W, Earle J, Mulroney SE, Goepfert H, Lanier A, Talvot ML, Pilch B, Goodman M, Huang A, Levine PH, Hyams V, Moran E, Henle G, Henle W. Cancer; 1983 Jan 15; 51(2):260-8. PubMed ID: 6295597 [Abstract] [Full Text] [Related]
13. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC). Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L. Cancer Detect Prev; 1981 Jan 15; 4(1-4):307-12. PubMed ID: 6299561 [Abstract] [Full Text] [Related]
15. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China. Zheng XH, Lu LX, Li XZ, Jia WH. Cancer Sci; 2015 Sep 15; 106(9):1196-201. PubMed ID: 26082292 [Abstract] [Full Text] [Related]
16. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma. Coghill AE, Bu W, Nguyen H, Hsu WL, Yu KJ, Lou PJ, Wang CP, Chen CJ, Hildesheim A, Cohen JI. Clin Cancer Res; 2016 Jul 15; 22(14):3451-7. PubMed ID: 26920891 [Abstract] [Full Text] [Related]
17. Relationship between the Epstein-Barr virus genome and nasopharyngeal carcinoma in Caucasian patients. Andersson-Anvret M, Forsby N, Klein G, Henle W, Biörklund A. Int J Cancer; 1979 Jun 15; 23(6):762-7. PubMed ID: 223991 [Abstract] [Full Text] [Related]
18. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX. Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282 [Abstract] [Full Text] [Related]
19. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma. Hewetson JF, Levine PH, Neubauer RH, Rabin H. Int J Cancer; 1982 Nov 15; 30(5):581-5. PubMed ID: 6295966 [Abstract] [Full Text] [Related]
20. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck. Ringborg U, Henle W, Henle G, Ingimarsson S, Klein G, Silfversward C, Strander H. Cancer; 1983 Oct 01; 52(7):1237-43. PubMed ID: 6309355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]